Andrew J. Aschenbrenner
Washington University in St. Louis(US)Hope Center for Neurological Disorders(US)Prevent Alzheimer’s Disease 2020(US)
Publications by Year
Research Areas
Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Functional Brain Connectivity Studies, Health, Environment, Cognitive Aging, Neural and Behavioral Psychology Studies
Most-Cited Works
- → A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease(2021)354 cited
- → Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease(2018)280 cited
- → Tau PET in autosomal dominant Alzheimer’s disease: relationship with cognition, dementia and other biomarkers(2019)181 cited
- → Additive effects of word frequency and stimulus quality: The influence of trial history and data transformations.(2013)137 cited
- → Disease staging of Alzheimer’s disease using a CSF-based biomarker model(2024)101 cited
- → Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer’s disease(2022)94 cited